Nitroglycerin (NTG) is an important cardiovascular agent, but tolerance dur
ing continuous administration limits its clinical utility. Increased vascul
ar superoxide production may mediate nitrate tolerance via a reduction in n
itric oxide availability. Because superoxide anion and nitric oxide react a
vidly to form peroxynitrite, an aggressive cellular toxicant that nitrates
protein tyrosine residues, we tested the hypotheses that protein nitration,
indicative of peroxynitrite formation, occurs during vascular tolerance, a
nd that protein nitration participates in tolerance development. Preincubat
ion of rat thoracic aorta segments with NTG (22 mu M, EC95 for 30 min) caus
ed a significant shift in NTG relaxation response (EC50; 6.7 +/- 1.7 versus
0.50 +/- 0.13 mu M, NTG versus vehicle, p<.05). After functional evaluatio
ns, tissues were fixed in formalin for immunohistochemistry and digital ima
ge analysis. NTG-induced vascular tolerance was associated with increased i
mmunoprevalence of 3-nitrotyrosine (3NT, stable biomarker of protein nitrat
ion; 11.41 +/- 2.48 versus 0.04 +/- 0.02% positive pixels, NTG versus vehic
le, p<.05). Staining was observed throughout vascular smooth muscle layers.
Addition of 500 mu M free tyrosine to the preincubation medium did not alt
er tolerance development (NTG EC50 6.5 +/- 3.0 mu M) but abolished 3NT immu
noprevalence (0.16 +/- 0.10%). No significant relationship between NTG pote
ncy and 3NT immunoprevalence was observed. These data support the hypothesi
s that protein nitration occurs during nitrate vascular tolerance, however,
it apparently does not mediate this phenomenon.